Antibody-drug Conjugate Information

General Information of This Antibody-drug Conjugate (ADC)

ADC ID	DRG0LSVWJ
ADC Name	SGN-CD47M
Synonyms	SGN-CD47M; SGN CD47M; SGNCD47M Click to Show/Hide
Organization	Seagen Inc.
Drug Status	Phase 1 (Terminated)
Indication	In total 9 Indication(s) Breast cancer Phase 1 Clinical Trial Colorectal cancer Phase 1 Clinical Trial Gastric cancer Phase 1 Clinical Trial Head and neck cancer Phase 1 Clinical Trial Lung cancer Phase 1 Clinical Trial Melanoma Phase 1 Clinical Trial Osteosarcoma Phase 1 Clinical Trial Ovarian cancer Phase 1 Clinical Trial Pancreatic cancer Phase 1 Clinical Trial
Drug-to-Antibody Ratio	Undisclosed
	3D MOL	2D MOL
Antibody Name	A humanized antiCD47 IgG1 mAb		Antibody Info
Antigen Name	Leukocyte surface antigen CD47 (CD47)		Antigen Info
Payload Name	Monomethyl auristatin E		Payload Info
Therapeutic Target	Microtubule (MT)		Target Info
Conjugate Type	Undisclosed